GSK plc
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GSKN.MX | MRK | JNJ.NE | GILD | JNJ | AZN | |
|---|---|---|---|---|---|---|
| Market cap | 1.72T | 367.67B | 847.01B | 190.64B | 617.99B | 260.96B |
| P/E (TTM) | 15.0 | 118.3 | 23.5 | — | 38.9 | 25.2 |
| Forward P/E | — | 16.0 | — | 15.4 | 22.1 | 14.8 |
| Price/book | 4.0 | 8.8 | 0.7 | 16.1 | 7.3 | 5.2 |
| Dividend yield | 3.76% | 2.29% | 2.49% | 2.10% | 2.07% | 1.90% |
| 1-year change | +6.08% | +69.27% | +40.84% | +28.86% | +34.43% | +1.17% |
| Today | 0.00% | +0.49% | −1.12% | −1.76% | −1.13% | −0.33% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All GSKN.MX news ›Australia's CSL names GSK executive Waterhouse as next CEO
By Nikita Maria Jino and Roshan Thomas Waterhouse will be the first woman to lead CSL since it was incorporated more than three decades ago. She will replace interim CEO Gordon Naylor and be based in Britain, the Melbourne-headquartered…
New Hope for Hepatitis B Patients: US Approves GSK's Hibsago
Washington, D.C. – The United States has given its nod to a new treatment for chronic hepatitis B, offering a ray of hope for patients. The US Food and Drug Administration (FDA) announced on Tuesday the approval of Hibsago (bepirovirsen),…
Viola Davis Joins GSK Shingles Awareness Campaign
If consumers are scheduling a flu or COVID shot this time of year, their pharmacy or doctor may well suggest getting other vaccines -- perhaps, if they're 50 or over, for shingles. Why protect against shingles? EGOT winner Viola Davis can…
GSK secures US approval for hepatitis B drug Hibsago.
Drugmaker GSK said on Wednesday that the US Food and Drug Administration had approved Hibsago (bepirovirsen) for the treatment of chronic hepatitis B in adults without cirrhosis, marking the first approval of an antisense oligonucleotide…
GSK wins US approval for functional cure for chronic hepatitis B
Faglig rådgiver til ATMP Danmark Head of Clinical Operations Senior Drug Product Filling Specialist Nordic Head of Commercial Excellence Chef for Kvalitet og Compliance Senior Drug Substance Scientist Head of Medical Affairs International…
US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment
The drug, chemically known as bepirovirsen, is the first FDA-approved antisense oligonucleotide for chronic hepatitis B, according to the agency. Under new CEO Luke Miels, GSK is aiming to speed up the develop and launch of new medicines…
Being poor makes you go faster as you have nothing much to loose: GSK Velu
In this video, Dr G.S.K. Velu talks about entrepreneurship, the dignostics sector and how poverty can accelerate action due to fewer risks. Velu talks about entrepreneurship, the dignostics sector and how poverty can accelerate action due…
GSK’s Jemperli Approved in MSI-H/dMMR Rectal Cancer
Jemperli (dostarlimab) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Jemperli…
GSK wins FDA approval for rectal cancer drug
Head of Medical Affairs International Markets Chef for Kvalitet og Compliance Senior Drug Product Filling Specialist Faglig rådgiver til ATMP Danmark Head of Clinical Operations Senior Drug Substance Scientist Nordic Head of Commercial…
GSK Investing $800M in Biopharma Manufacturing in Pennsylvania
Biopharmaceutical manufacturer GSK will invest more than $800 million to expand its operations in Upper Merion Township, Pennsylvania, according to a recent announcement from Gov. Josh Shapiro and the commonwealth’s economic development…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com32
-
themarketsdaily.com10
-
stocktitan.net8
-
seekingalpha.com6
-
tradingview.com6
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.